Synageva BioPharma (GEVA) to Host 2012 Fourth Quarter and Full Year Financial Results Conference Call on March 11
3/4/2013 6:16:43 AM
Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare diseases, will report 2012 fourth quarter and full year financial results after the NASDAQ Market closes on Monday, March 11, 2013. Synageva management will conduct a conference call and audio webcast to discuss these results as well as provide a general business update at 4:30 p.m. EST on the same day.
comments powered by